We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

13 hedge funds and large institutions have $21.7M invested in Aurinia Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

35% less capital invested

Capital invested by funds: $33.2M → $21.7M (-$11.5M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$352K
2
LOAMU
Lombard Odier Asset Management (USA)
New York
+$44.2K
3
Millennium Management
Millennium Management
New York
+$4.23K
4
Morgan Stanley
Morgan Stanley
New York
+$3.72K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.86K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$1.34M
2
Deutsche Bank
Deutsche Bank
Germany
-$581K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$152
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$7.69M – – –
GPP
2
Great Point Partners
Connecticut
$5.81M – – –
RCM
3
RA Capital Management
Massachusetts
$3.45M -$1.34M -362,100 -24%
BBA
4
Baker Bros. Advisors
New York
$2.13M – – –
ACP
5
Acuta Capital Partners
California
$1.58M +$352K +94,751 +22%
Millennium Management
6
Millennium Management
New York
$439K +$4.23K +1,139 +0.8%
LOAMU
7
Lombard Odier Asset Management (USA)
New York
$314K +$44.2K +11,915 +13%
CCMU
8
Cheyne Capital Management (UK)
United Kingdom
$274K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$33K -$152 -41 -0.4%
TRCT
10
Tower Research Capital (TRC)
New York
$14K +$1.86K +500 +16%
Morgan Stanley
11
Morgan Stanley
New York
$3K +$3.72K +1,002 +1,891%
1832 Asset Management
12
1832 Asset Management
Ontario, Canada
$1K +$742 +200 New
Bank of America
13
Bank of America
North Carolina
$1K +$1.48K +400 New
Deutsche Bank
14
Deutsche Bank
Germany
– -$581K -133,333 Closed

AUPH Hedge Fund Activity: Q2 2015 in Review

13 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q2 2015, worth a combined $21.7M — down 35% from $33.2M a quarter earlier.

Fund positioning in AUPH was balanced in Q2 2015: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 2 trimmed.

The largest buyer was Acuta Capital Partners, adding an estimated $352K. The largest seller was RA Capital Management, cutting an estimated $1.34M.

  • 13 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $21.7M of Aurinia Pharmaceuticals stock for Q2 2015, down 35% quarter-over-quarter.
  • 2 funds opened new Aurinia Pharmaceuticals positions in Q2 2015 and 2 closed out, a net change of 0 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q2 2015 was Acuta Capital Partners, an estimated $352K added.
  • The largest Aurinia Pharmaceuticals seller in Q2 2015 was RA Capital Management, an estimated $1.34M sold.

Based on aggregated 13F filings for Q2 2015.